Noticias de PRAX_US

Noticias del mercado

Últimas noticias sobre PRAX_US — 96 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: PRAX_US ✕ 96 resultados
01/06/2026 PRAX_US — Bitget
Praxis Precision Medicines, Inc. announces that its clinical trial has met a key secondary endpoint with a 50% response rate.
01/06/2026 PRAX_US — Bitget ES ← EN
Praxis Precision Medicines, Inc. anuncia que su ensayo clínico alcanzó un criterio de valoración secundario clave con una tasa de respuesta del 50%.

Praxis Precision Medicines, Inc. announces that its clinical trial has met a key secondary endpoint with a 50% response rate.

28/05/2026 PRAX_US — Yahoo Finance
Praxis Precision Medicines (PRAX): Best Mid Cap Stocks to Buy with Highest Upside Potential
27/05/2026 PRAX_US — Investing.com South Africa ES ← EN
Las acciones de Praxis Precision Medicines alcanzan su máximo de 52 semanas a 360,8 USD Por Investing.com

Praxis Precision Medicines stock hits 52-week high at 360.8 USD By Investing.com

27/05/2026 PRAX_US — Investing.com
Praxis Precision Medicines stock hits 52-week high at 360.8 USD
26/05/2026 PRAX_US — Investing.com
H.C. Wainwright reiterates Praxis Precision stock rating on patent news
19/05/2026 PRAX_US — Stock Titan
[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity
19/05/2026 PRAX_US — Stock Titan
Praxis (PRAX) CEO acquires 126 ESPP shares as compensation
19/05/2026 PRAX_US — Stock Titan
Praxis (NASDAQ: PRAX) accounting officer adds shares through employee stock purchase plan
19/05/2026 PRAX_US — Stock Titan
Praxis (NASDAQ: PRAX) COO adds shares through Employee Stock Purchase Plan
19/05/2026 PRAX_US — Stock Titan
Praxis (NASDAQ: PRAX) counsel adds 78 ESPP shares, holds 26,010.667
17/05/2026 PRAX_US — Yahoo Finance
Is FDA NDA Progress Amid Wider Losses Altering The Investment Case For Praxis Precision Medicines (PRAX)?
15/05/2026 PRAX_US — Stock Titan
[SCHEDULE 13G] Praxis Precision Medicines, Inc. Passive Investment Disclosure (>5%)
15/05/2026 PRAX_US — Stock Titan
Orbis and Allan Gray report 8.9% stake in Praxis Precision Medicines (PRAX)
15/05/2026 PRAX_US — Stock Titan
Point72 entities and Cohen report 0.2% stake in Praxis (PRAX)
13/05/2026 PRAX_US — Stock Titan
Praxis (PRAX) widens Q1 2026 loss while advancing four late-stage CNS drugs
13/05/2026 PRAX_US — Investing.com
Praxis Precision Medicines stock hits 52-week high at $358.01
11/05/2026 PRAX_US — Yahoo Finance
Wedbush Maintained an Underperform Rating on Praxis Precision Medicines, Inc. (PRAX)
08/05/2026 PRAX_US — Yahoo Finance
Praxis Precision Medicines, Inc. Q1 2026 Earnings Call Summary
08/05/2026 PRAX_US — Yahoo Finance
Praxis Precision Medicines Q1 Earnings Call Highlights

Página 3 de 5

keyboard_arrow_up